The Introduction of Robotics: Creating a Truly Sterile Environment

Biologics CDMO

What Drug Developers Should Look for in a Long-Term Biologics Manufacturing Partner

Angelika Rublack

IDT Biologika

Fed-Batch

Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization

Minyong Eom; Hakyung Kim; Dongyoung Park; Sojeong Lee, Ph.D.; Daegyun Lee

Samsung Biologics

Analytical Strategy

Analytical Strategy as a Competitive Advantage in Biologics Development

Dr. Dietmar Mayer

IDT Biologika

Distributor

Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development

Daisy Huerta

Ingredients + Specialties from Univar Solutions

Antibody Data

Does Antibody Development Have a Data Problem?

Sophie Lutter, Ph.D.

Lab Thread

Orthogonal Methods

Orthogonal Analytics: How Much Characterization Is Enough?

David Alvaro, Ph.D.

Pharma's Almanac

SmartScale

Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model

Jesse McCool, Ph.D.

GBI Biomanufacturing

Data-Driven Mfg

Data-Driven Manufacturing and Digital Twins Across the Biologics Network

Jihyeon Oh; Hongwoo Joo

Samsung Biologics

CLD

Can Mammalian Cell-Line Engineering Become a High-Throughput Design Problem?

Pharma's Almanac

Bioprocessing

Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty

Cynthia A. Challener, Ph.D.

Pharma's Almanac

DS + DP Integration

Integrating Drug Substance and Drug Product to Reduce Risk Across Development

Dörthe Ackenhausen

IDT Biologika

Multi-Modality CDMO

The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity

Kamal Preet

OneSource Specialty Pharma